An Update on the Evaluation and Management of Pulmonary Hypertension in Scleroderma.

Author: Coghlan JG, Schrieber B.
Date Published: January-2012
Source: Current Rheumatology Reports

Pulmonary arterial hypertension associated with scleroderma (SScPAH) is a debilitating, highly lethal condition that responds to an array of therapies. Quality of life and prognosis are substantially improved by treatment, and early diagnosis and treatment are associated with improved outcomes.


AddThis Social Bookmark Button